Level of kidney function as a risk factor for cardiovascular outcomes in the elderly

Kidney International

Volumn 63, Issue 3, 2003, Pages 1121-1129

  Manjunath, Guruprasad ^b   Tighiouart, Hocine ^b   Coresh, Josef ^b   MacLeod, Bonnie ^b   Salem, Deeb N ^b   Griffith, John L ^b   Levey, Andrew S ^b   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cardiovascular disease; Glomerular filtration rate; Kidney disease

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD ASSESSMENT; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 12244269700     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00838.x     Document Type: Article

References (33)

1. CLINICAL PRACTICE GUIDELINES FOR CHRONIC KIDNEY DISEASE: Evaluation, classification, and stratification. Am J Kidney Dis 39(Suppl 1):S17-S31, 2002
2. SARNAK MJ, LEVEY AS: Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 35(4 Suppl 1):S117-S131, 2000
3. SHLIPAK MG, SIMON JA, GRADY D, et al: Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38:705-711, 2001
4. MANN JF, GERSTEIN HC, POGUE J, et al: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134:629-636, 2001
5. DRIES DL, EXNER DV, DOMANSKI MJ, et al: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35:681-689, 2000
6. MCCULLOUGH PA, SOMAN SS, SHAH SS, et al: Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 36:679-684, 2000
7. MATTS JP, KARNEGIS JN, CAMPOS CT, et al: Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. POSCH Group. J Fam Pract 36:497-503, 1993
8. CULLETON BF, LARSON MG, WILSON PW, et al: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214-2219, 1999
9. GARG AX, CLARK WF, HAYNES RB, HOUSE AA: Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 61:1486-1494, 2002
10. MUNTNER P, HE J, HAMM L, et al: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745-753, 2002
11. THOM TJ, KANNEL WB, SILBERSHATZ H, D'AGOSTINO RB: Incidence, prevalence, and mortality of cardiovascular diseases in the United States, in Hurst's The Heart: Arteries and Veins, edited by ALEXANDER RW, St. Louis, McGraw-Hill, 1998, pp 3-17
12. FRIED LP, BORHANI NO, ENRIGHT P, et al: The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1:263-276, 1991
13. FRIED LP, KRONMAL RA, NEWMAN AB, et al: Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 279:585-592, 1998
14. TELL GS, FRIED LP, HERMANSON B, et al: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 3:358-366, 1993
15. LEVEY AS, BOSCH JP, LEWIS JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
16. CORESH J, ASTOR BC, MCQUILLAN G, et al: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39:920-929, 2002
17. SMITH HW: Comparative physiology of the kidney, in The Kidney Structure and Function in Health and Disease, edited by SMITH HW, New York, Oxford University Press, 1951, pp 520-574
18. DAVIES DF, SHOCK NW: Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29:496-507, 1949
19. PAH in adult males. J Clin Invest 34:969, 1955
20. PSATY BM, KULLER LH, BILD D, et al: Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5:270-277, 1995
21. IVES DG, FITZPATRICK AL, BILD DE, et al: Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 5:278-285, 1995
22. NIETO FJ, CORESH J: Adjusting survival curves for confounders: A review and a new method. Am J Epidemiol 143:1059-1068, 1996
23. RUILOPE LM, SALVETTI A, JAMERSON K, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12:218-225, 2001
24. SCHILLACI G, REBOLDI G, VERDECCHIA P: High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 161:886-891, 2001
25. FLACK JM, NEATON JD, DANIELS B, ESUNGE P: Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis 21(4 Suppl 1):31-40, 1993
26. SHULMAN NB, FORD CE, HALL WD, et al: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-up Program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(Suppl 5):I80-I93, 1989
27. KASISKE BL: The kidney in cardiovascular disease. Ann Intern Med 134:707-709, 2001
28. BOSTOM AG, LATHROP L: Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10-20, 1997
29. KOCH M, KUTKUHN B, TRENKWALDER E, et al: Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 8:1889-1898, 1997
30. HILLEGE HL, GIRBES AR, DE KAM PJ, et al: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203-210, 2000
31. WACHTELL K, OLSEN MH, DALHOF B, et al: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertens 20:353-355, 2002
32. GERSTEIN HC, MANN JF, YI Q, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421-426, 2001
33. YUDKIN JS, FOREST RD, JACKSON CA: Microalbuminuria as a predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 2:530-533, 1988